Help | RSS Feed

Brainstorm Cell Therapeutics Inc. (NASD:BCLI) Seasonal Chart

Brainstorm Cell Therapeutics Inc. (NASD:BCLI) Seasonality

BCLI Relative to the S&P 500
BCLI Relative to the S&P 500

BCLI Relative to the Sector
BCLI Relative to the Sector

Monthly Seasonal Brainstorm Cell Therapeutics Inc. (NASD:BCLI)

Seasonal Chart Analysis

Analysis of the Brainstorm Cell Therapeutics Inc. (NASD:BCLI) seasonal charts above shows that a Buy Date of November 26 and a Sell Date of March 19 has resulted in a geometric average return of 21.97% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 38.25% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore